Literature DB >> 8443823

Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity.

T Hennet1, G Bertoni, C Richter, E Peterhans.   

Abstract

Tumor necrosis factor (TNF) kills some types of tumor cells in vitro and participates in tumor elimination in vivo. TNF has been shown to kill cells by altering their mitochondria structurally and functionally. The oncogene BCL-2 codes for a protein located in the inner membrane of mitochondria which is able to inhibit the commitment to cell death in various cell types. We have therefore investigated whether TNF-mediated killing of the cell line L929 could be modulated by expression of the protein BCL-2. We report here that L929 cells transfected with a BCL-2 expression vector have an increased survival compared to wild type cells after TNF challenge. The protective effect is greatest at moderate TNF concentrations and is still significant at concentrations that killed 100% of wild type cells. The action of BCL-2 is selective inasmuch as cells are not protected against other cytotoxic agents blocking various mitochondrial functions. We show that cells expressing BCL-2 have a higher mitochondrial membrane potential (delta psi) than wild type cells. The increase in delta psi could be linked with the enhanced survival of cells after TNF challenge. Indeed, we found that treatment of wild type L929 cells with the ionophore nigericin, which increases delta psi, protects them even at high TNF concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443823

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death.

Authors:  P Mehlen; C Kretz-Remy; X Préville; A P Arrigo
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Nitidine chloride induces apoptosis, cell cycle arrest, and synergistic cytotoxicity with doxorubicin in breast cancer cells.

Authors:  Mingjuan Sun; Ning Zhang; Xiaolong Wang; Chang Cai; Jinjing Cun; Yaming Li; Shangge Lv; Qifeng Yang
Journal:  Tumour Biol       Date:  2014-07-17

3.  Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.

Authors:  E Bossy-Wetzel; D D Newmeyer; D R Green
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

4.  Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function.

Authors:  M Higuchi; B B Aggarwal; E T Yeh
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Channel formation by antiapoptotic protein Bcl-2.

Authors:  S L Schendel; Z Xie; M O Montal; S Matsuyama; M Montal; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 6.  Potential roles for tumour necrosis factor alpha during embryonic development.

Authors:  M A Wride; E J Sanders
Journal:  Anat Embryol (Berl)       Date:  1995-01

7.  Activation of cyclin A-dependent protein kinases during apoptosis.

Authors:  W Meikrantz; S Gisselbrecht; S W Tam; R Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells.

Authors:  S K Chiou; C C Tseng; L Rao; E White
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis.

Authors:  P A Fernandez; R J Rotello; Z Rangini; A Doupe; H C Drexler; J Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

10.  Differential protection by wildtype vs. organelle-specific Bcl-2 suggests a combined requirement of both the ER and mitochondria in ceramide-mediated caspase-independent programmed cell death.

Authors:  Andrea Deerberg; Justyna Sosna; Lutz Thon; Claus Belka; Dieter Adam
Journal:  Radiat Oncol       Date:  2009-10-09       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.